MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock and...
$120,000K
Proceeds from exercise of
stock options
$6K
Net cash provided by
financing activities
$114,941K
Canceled cashflow
$5,065K
Net (decrease)
increase in cash, cash...
$87,278K
Canceled cashflow
$27,663K
Payments from sale of
common stock and...
$4,875K
Payment of withholding
taxes for stock-based...
$190K
Stock-based compensation
expense
$2,824K
Accounts payable
$1,490K
Non-cashinterest expense related
to term loan
$206K
Non-cashlease expense
$200K
Depreciation
$184K
Change in other, net
$116K
Loss on disposal of
assets
-$9K
Net cash used in
operating activities
-$27,091K
Net cash used in
investing activities
-$556K
Effect of exchange rate
changes on cash, cash...
-$16K
Canceled cashflow
$5,029K
Net loss
-$26,237K
Prepaid expenses and
other assets
$4,130K
Capital expenditures
$556K
Accrued liabilities and
other liabilities
-$1,753K
Back
Back
Cash Flow
Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc. (ANRO)
source: myfinsight.com